Lucid Diagnostics Inc. Gain (Loss) on Extinguishment of Debt
Lucid Diagnostics Inc. (LUCD) reported Gain (Loss) on Extinguishment of Debt of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-03-25
- Lucid Diagnostics Inc. gain (loss) on extinguishment of debt for the quarter ending 2024-12-31 was -$4.05M.
- Lucid Diagnostics Inc. gain (loss) on extinguishment of debt for the quarter ending 2024-09-30 was -$435.00K.
- Lucid Diagnostics Inc. gain (loss) on extinguishment of debt for the quarter ending 2024-06-30 was -$513.00K.
- Lucid Diagnostics Inc. gain (loss) on extinguishment of debt for the quarter ending 2024-03-31 was -$167.00K.
- Lucid Diagnostics Inc. gain (loss) on extinguishment of debt for fiscal 2025 was $0.00.
- Lucid Diagnostics Inc. gain (loss) on extinguishment of debt for fiscal 2024 was -$5.17M.
- Lucid Diagnostics Inc. gain (loss) on extinguishment of debt for fiscal 2023 was -$26.00K.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-25 | |||
| 2024-12-31 | -$4.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$4.49M derived: sum of 2 quarters · filed 2026-03-25 | -$5.00M derived: sum of 3 quarters · filed 2026-03-25 | -$5.17M 10-K · filed 2026-03-25 |
| 2024-09-30 | -$435.00K 10-Q · filed 2025-11-12 | -$948.00K derived: sum of 2 quarters · filed 2025-11-12 | -$1.12M 10-Q · filed 2025-11-12 | -$1.11M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$513.00K 10-Q · filed 2025-08-12 | -$681.00K 10-Q · filed 2025-08-12 | -$680.00K derived: sum of 3 quarters · filed 2025-08-12 | -$706.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$167.00K 10-Q · filed 2025-05-13 | -$167.00K derived: sum of 2 quarters · filed 2025-05-13 | -$193.00K derived: sum of 3 quarters · filed 2025-05-13 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$26.00K derived: sum of 2 quarters · filed 2025-03-24 | -$26.00K 10-K · filed 2025-03-24 | |
| 2023-09-30 | -$26.00K 10-Q · filed 2024-11-12 | -$26.00K 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |